Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nippon Carbide Industries is a Japanese chemical and materials company that operates a specialized medical division focused on Transdermal Drug Delivery Systems (TDDS). Leveraging its expertise in adhesive and film technologies, the company develops and manufactures pharmaceutical patches for a variety of therapeutic areas, including pain management and respiratory care. NCI functions as a Contract Development and Manufacturing Organization (CDMO), providing integrated services from formulation design to commercial production. The company is publicly traded on the Tokyo Stock Exchange and maintains a global presence through its functional materials and electronic components businesses.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nippon Carbide Industries.